- Release Date: 16/03/23 10:36
- Summary: FDA approval of expanded indication of Illuccix in the US
- Price Sensitive: Yes
- Download Document 169.06KB
- Forums
- ASX - By Stock
- TLX
- Ann: FDA approval of expanded indication of Illuccix in the US
Ann: FDA approval of expanded indication of Illuccix in the US
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$22.96 |
Change
-0.510(2.17%) |
Mkt cap ! $7.662B |
Open | High | Low | Value | Volume |
$23.25 | $23.36 | $22.78 | $17.61M | 765.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 608 | $22.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.97 | 357 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 57 | 22.960 |
5 | 602 | 22.950 |
7 | 601 | 22.940 |
10 | 968 | 22.930 |
6 | 4101 | 22.920 |
Price($) | Vol. | No. |
---|---|---|
22.980 | 1222 | 7 |
22.990 | 1134 | 7 |
23.000 | 2059 | 12 |
23.010 | 696 | 4 |
23.020 | 912 | 6 |
Last trade - 14.54pm 13/11/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online